Topics

CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) ...

18:02 EDT 1 Oct 2019 | BioMedReports - Blog

VANCOUVER, Washington, Oct. 01, 2019 (GLOBE NEWSWIRE)

Read more...

Original Article: CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) ...

NEXT ARTICLE

More From BioPortfolio on "CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) ..."

Quick Search